Ian Clements, Chief Financial Officer at Mirum Pharmaceuticals, Inc. (MIRM), bought 2,470 shares at $18.55 ($46K) on 2020-12-23, disclosed to the SEC on 2020-12-28.
High-signal trade — passes our conviction filters but the AI narrative is still being generated. Check back shortly.
Something here stands out, but not much.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $18.55 | 908 | $17K | 36.6% |
| 2 | $18.65 | 1,562 | $29K | 63.4% |
| Total | $18.61 avg | 2,470 | $46K | 100% |
| Filing → |
| MIRM | BUY | 2021-03-08 | $30K | — | Filing → |
| MIRM | BUY | 2019-09-10 | $46K | — | Filing → |